NRX Pharmaceuticals (NRXP) Treasury Shares (2017 - 2026)
NRX Pharmaceuticals' (NRXP) quarterly Treasury Shares came in at $32895.0 in Q1 2026, little changed on a QoQ basis from $32895.0 in Q4 2025.
NRX Pharmaceuticals (NRXP) Treasury Shares (2017 - 2026) Analysis & Trends
NRX Pharmaceuticals (NRXP) has 8 years of Treasury Shares data on file, last reported at $32895.0 in Q1 2026.
- On a quarterly basis, Treasury Shares changed N/A year-over-year to $32895.0 in Q1 2026; TTM through Mar 2026 was $32895.0, a N/A change from a year earlier, with the FY2025 full-year figure at $32895.0, changed N/A from the prior year.
- Treasury Shares for Q1 2026 stood at $32895.0, roughly flat from $32895.0 in the prior quarter.
- Over the last five years, Treasury Shares for NRXP reached as high as $1.0 million in Q3 2022 and fell as low as $32895.0 in Q4 2025.
- Historically, Treasury Shares has averaged $456662.5 across 5 years, with a median of $124166.0 in 2023.
- Across the five-year window, Treasury Shares tumbled 33.33% in 2023 and tumbled 95.0% in 2024, its largest moves.
- Year by year, Treasury Shares stood at $1.0 million in 2022, then tumbled by 87.58% to $124166.0 in 2023, then sank by 73.15% to $33333.0 in 2024, then fell by 1.31% to $32895.0 in 2025, then changed by 0.0% to $32895.0 in 2026.
- Per Business Quant data, the three most recent Treasury Shares figures were $32895.0 in Q1 2026, $32895.0 in Q4 2025, and $33333.0 in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,402.79 Bn | 67,402.51 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,930.72 Bn | 1,930.66 Bn | - | 265,401.92 |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 471.98 Bn | 467.19 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 123.50 Bn | 116.25 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 70.37 Bn | 61.61 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.41 Bn | 62.41 Bn | - | - |
| 8 | Argenx Se | 56.13 Bn | 50.94 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.51 Bn | 37.51 Bn | - | 5.14 Mn |
| 10 | NRX Pharmaceuticals | 120.25 Mn | 113.55 Mn | 437,000.00 | 32,895.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32,895.00 |
| Mar 31, 2026 | 32,895.00 |
| Dec 31, 2025 | 32,895.00 |
| Dec 31, 2025 | 32,895.00 |
| Sep 30, 2024 | 33,333.00 |
| Sep 30, 2024 | 33,333.00 |
| Jun 30, 2024 | 66,666.00 |
| Jun 30, 2024 | 66,666.00 |
| Mar 31, 2024 | 66,666.00 |
| Mar 31, 2024 | 66,666.00 |
| Dec 31, 2023 | 124,166.00 |
| Dec 31, 2023 | 124,166.00 |
| Sep 30, 2023 | 666,667.00 |
| Sep 30, 2023 | 666,667.00 |
| Jun 30, 2023 | 1.00 Mn |
| Jun 30, 2023 | 1.00 Mn |
| Mar 31, 2023 | 1.00 Mn |
| Mar 31, 2023 | 1.00 Mn |
| Dec 31, 2022 | 1.00 Mn |
| Dec 31, 2022 | 1.00 Mn |